
At meeting on guardrails for gene editing of human embryos, some call for a dead end
WASHINGTON — Keith Joung knows better than a lot of people what, exactly, it might require to prove to regulators and patients that CRISPR could be safely used to alter the genome of a human embryo. If, of course, society decided that was a good idea. …